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Oxidative stressDysregulation of Ca2+ has long been implicated to be important in cell injury. A Ca2+-linked process
important in necrosis and apoptosis (or necrapoptosis) is the mitochondrial permeability transition (MPT).
In the MPT, large conductance permeability transition (PT) pores open that make the mitochondrial inner
membrane abruptly permeable to solutes up to 1500 Da. The importance of Ca2+ in MPT induction varies
with circumstance. Ca2+ overload is sufﬁcient to induce the MPT. By contrast after ischemia–reperfusion to
cardiac myocytes, Ca2+ overload is the consequence of bioenergetic failure after the MPT rather than its
cause. In other models, such as cytotoxicity from Reye-related agents and storage-reperfusion injury to liver
grafts, Ca2+ appears to be permissive to MPT onset. Lastly in oxidative stress, increased mitochondrial Ca2+
and ROS generation act synergistically to produce the MPT and cell death. Thus, the exact role of Ca2+ for
inducing the MPT and cell death depends on the particular biologic setting.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionFree Ca2+ is a key signaling agent in eukaryotic cells. Hormonal
and other stimuli activate phospholipase C, isositol triphosphate
formation and mobilization of Ca2+ from the endoplasmic reticulum
[3,5]. In excitable tissues, membrane depolarization also causes Ca2+
entry through voltage gated Ca2+ channels. Increased cytosolic free
Ca2+ then activates protein kinases and in striated muscle stimulates
release of Ca2+ from sarcoplasmic reticulum to activate muscle
contraction. Inﬂux of Ca2+ into the cytosol also leads to mitochondrial
accumulation of Ca2+ and activation of respiratory dehydrogenases
and oxidative phosphorylation [35]. Most unstimulated cells tightly
regulate free Ca2+ in the range of 100 to 200 nM in both the cytosol
and themitochondria through action of membrane Ca2+ pumps in the
plasma membrane and endoplasmic/sarcoplasmic reticulum, Na/Ca
exchange across the plasma membrane and, to a lesser extent,
mitochondrial Ca2+ uptake. Thus, cytosolic free Ca2+ is substantially
lower than the 2 mM free Ca2+ present in extracellular ﬂuids. With
physiologic stimulation, however, free Ca2+ in both cytosol and
mitochondria can rapidly and transiently increases by 10 to 20-fold as
occurs on a beat to beat basis in cardiac myocytes due to
mitochondrial Ca2+ uptake [48].
Dysregulation of Ca2+ homeostasis has long been implicated to
play an important role in cell injury. Pathological Ca2+ overload andry and Regeneration, Medical
g, 280 Calhoun Street, PO Box
s).
ll rights reserved.calciﬁcation are frequently features of tissue ischemia and infarction,
and increased Ca2+ activates a number of phosphatases, proteases and
nucleases. Early experimental studies in hepatocytes showed that
removal of extracellular Ca2+ protects against various hepatotoxi-
cants, suggesting that inﬂux of extracellular Ca2+ is responsible for
irreversible cell injury [13,44]. Since maintenance of Ca2+ gradients
across the plasma membrane and between cellular compartments
depends on ATP-driven reactions, metabolic disruption by injurious
stresses may quickly perturb cellular Ca2+ homeostasis. In particular,
release of Ca2+ from the endoplasmic reticulummay ﬂood the cytosol
with free Ca2+, possibly leading to activation of degradative processes
and dysfunction of other organelles, particularly mitochondria [39].
However, other early work indicated that cytosolic free Ca2+ does not
rise preceding hypoxic cell death and therefore may not contribute to
the pathogenesis of lethal cell injury after ATP depletion [32].
2. Mitochondrial permeability transition
A Ca2+-linked process important in many instances of both
necrotic and apoptotic cell death is the mitochondrial permeability
transition (MPT). In the MPT, large conductance permeability
transition (PT) pores open that make the mitochondrial inner
membrane abruptly permeable to all solutes of molecular weight up
to about 1500 Da [2,21,25]. Ca2+, numerous reactive chemicals and
oxidative stress induce PT pore opening, whereas cyclosporin A (CsA)
and pH less than 7 block opening. As a consequence of the MPT,
mitochondrial depolarization, uncoupling of oxidative phosphoryla-
tion and large-amplitude mitochondrial swelling driven by colloid
osmotic forces occur.
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the adenine nucleotide transporter (ANT) from the inner membrane,
the voltage dependent anion channel (VDAC) from the outer
membrane, the CsA binding protein cyclophilin D (CypD) from the
matrix, and possibly other proteins form PT pores (reviewed in
[10,17]). However, recent genetic knockout studies challenge the
validity of this model by showing that the MPT still occurs in
mitochondria that are deﬁcient in ANT, VDAC and even CypD, although
some properties of the MPT are altered [2,23,28,29]. For example in
ANT deﬁcient mitochondria, the ANT ligand, atractyloside, no longer
promotes PT pore opening, whereas in CypD deﬁcient mitochondria,
MPT induction requires greater Ca2+ and is not blocked by CsA.
An alternative model proposes that damage by reactive chemicals,
oxidative stress, thiol crosslinking and other perturbations cause
misfolding of integral membrane proteins [18]. Misfolding creates
hydrophilic surfaces that face the lipid bilayer, a thermodynamically
unfavorable condition. Consequently, misfolded membrane proteins
aggregate at these hydrophilic surfaces to create aqueous transmem-
brane channels, which are the nascent PT pores. To prevent
catastrophic permeabilization and uncoupling of oxidative phosphor-
ylation, CypD and other molecular chaperones acting from both sides
of the inner membrane block conductance through these nascent PT
pores. CypD like other cyclophilins is a cis–trans peptidyl proline
isomerase, namely a foldase, which may have a physiological role of
promoting refolding of the misfolded proteins back to their native
state [51]. However, CypD binding also makes PT pores sensitive to
reversible Ca2+-induced opening, an action inhibited by CsA. When
nascent PT pores formed by misfolded protein aggregates exceed the
content of chaperones available to block their conductance, pore
opening occurs in an unregulated fashion. Such unregulated pore
opening is insensitive to CsA inhibition and no longer requires Ca2+ to
occur. In addition to CypD, other as yet poorly characterized
chaperones are involved in regulating conductance by nascent PT
pores. Indirect evidence suggest that the Rieske iron sulfur protein
(RISP) and the heat shock protein Hsp27 may participate in regulating
PT pore conductance [19,20]. In particular, dephosphorylation of RISP
may be an important event promoting pore opening.
In the protein misfolding model, any membrane protein in
principle might contribute to pore formation, but abundance and
propensity to misfold determine the likelihood of a particular
membrane protein to contribute to the MPT. As the most abundant
inner membrane protein on a molar basis, ANT frequently is the target
of damage causing misfolding. Moreover, ANT undergoes large
conformation changes, and the atractyloside-stabilized conformation
appears to be particularly vulnerable to damage leading to misfolding
and PT pore formation (reviewed in [33]). Other proteins can also
misfold and contribute to PT formation. For example, both old and
recent evidence suggests that other anion transporters, such as the
aspartate–glutamate and phosphate carriers, participate in formation
of large conductance pores [11,12,33,34,45]. Because PT pores can form
from these other membrane proteins, the MPT still occurs in ANT
deﬁcient mitochondria [28].
The misfolded protein model also accounts for why completely
exogenous pore-forming peptides like mastoparan and alamethicin
form CsA-sensitive PT pores [18,41]. Chaperones recognize and
regulate mastoparan and alamethicin pores in the same way as
endogenous PT pores. When pores formed by exogenous pore-
forming peptides are at low concentration, chaperones block their
conductance, but these regulated pores open in response to increased
matrix Ca2+ in a CsA-sensitive fashion. However, when the concen-
tration of exogenous pore formers exhaust the supply of chaperones,
constitutively open CsA insensitive pores form even in the absence of
Ca2+. Such behavior for mastoparan and alamethicin is conﬁrmed
experimentally [18]. Also as predicted by themisfolded protein model,
mitochondria from CypD knockout mice are desensitized to Ca2+
induction of the MPT and require much higher Ca2+ to inducemitochondrial swelling [1], which is consistent with the proposed role
of CypD as the Ca2+ sensor of the MPT.
Kinetic analysis of mitochondrial swelling after the MPT suggests
that the diameters (conductances) of individual pores are hetero-
geneous [36]. Such variation is consistent with a variable protein
composition for individual PT pores. Protein misfolding promoting PT
pore formation should not be equated with irreversible protein
denaturation. Indeed, reversal of protein misfolding may be an
important physiological function of CypD. When ANT is the principal
misfolded membrane protein contributing to PT pore formation,
bongkrekic acid by inducing the more stable m-conformation of ANT
may also be effective in reversing misfolding and pore opening [17].
3. Multiple roles of calcium in permeability transition-dependent
cell injury
Many chemicals and radicals promote the MPT. Typically the effect
of such inducers is to decrease the threshold amount of Ca2+ needed
to cause PT pore opening. In pathological settings where the MPT
contributes to cell killing, Ca2+may have several roles. First, increased
Ca2+ alone and its uptake into mitochondria may cause MPT onset.
Second, other stressors may decrease the threshold for the Ca2+-
inducedMPT such that Ca2+ need not change but is still permissive for
MPTonset. Lastly, stressors and increased Ca2+may act synergistically
to induce the MPT.
3.1. Induction of the MPT and cell death by calcium overload
That increased Ca2+ alone can cause the MPT and cell death is
supported by experiments with Br-A23187, a Ca2+ ionophore [42]. In
cultured rat hepatocytes, Br-A23187 causes rapid mitochondrial
depolarization and inner membrane permeabilization, as shown by
confocal microscopy from mitochondrial release of tetramethylrho-
damine methylester (TMRM), a potential-indicating ﬂuorophore, and
mitochondrial uptake of calcein, a 623 Da ﬂuorophore that is normally
impermeant to the inner membrane. After the Br-A23187-induced
onset of the MPT, necrotic cell death occurs from ATP depletion.
However, if an alternative source of ATP as from glycolysis, then
necrosis is prevented. Instead, caspase-dependent apoptosis occurs
secondary to release of cytochrome c and other pro-apoptotic factors
from the mitochondrial intermembrane space after outer membrane
rupture. CsA prevents both necrosis and apoptosis induced by Br-
23187, conﬁrming the important role of the MPT in both phenotypes
of cell death. Similarly after MPT-dependent ischemia–reperfusion
injury, the presence or absence of ATP determines whether apoptosis
or necrosis occurs [27]. The term, necrapoptosis, describes such death
processes that begin with a common death signal or toxic stress,
progress by shared pathways, and culminate in either plasma
membrane failure (necrosis) or programmed cellular resorption
(apoptosis) depending on other modifying factors [30,31].
3.2. Permissive role of calcium in cell death caused by
Reye-related toxicants
Reye's and Reye-related syndromes are often fatal illnesses
characterized by high fever, fulminant hepatic failure and encephalo-
pathy in children and sometimes adults in association with ingestion
of aspirin, valproic acid, unripened fruit of the ackee tree and other
toxicants [40]. Electron microscopy of liver and brain from these
patients shows large-amplitudemitochondrial swelling, suggestive on
onset of the MPT. In isolated liver mitochondria, Reye-related
toxicants do not by themselves induce the MPT but instead lower
the Ca2+ threshold for the MPT [49].
Salicylate, the active metabolite of aspirin, is directly cytotoxic to
cultured rat hepatocytes [50]. CsA blocks this cytotoxicity, and
confocal microscopy shows that CsA-sensitive mitochondrial
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salicylate exposure. A permissive role of Ca2+ in salicylate toxicity is
shown by cytoprotectionwith the Ca2+ channel blocker, verapamil, an
effect associatedwith decreasedmitochondrial free Ca2+measured by
confocal microscopy using the Ca2+ indicator, Rhod-2. Similarly in
support of a permissive role for Ca2+, increased extracellular Ca2+
promotes salicylate-induced cell killing. Synergism between salicylate
and Ca2+ may help account for the idiopathic nature of Reye's
syndrome. The vast majority of individuals taking aspirin experience
no liver or brain toxicity, but children with a prodromal viral illness
may incur higher mitochondrial Ca2+ loading, predisposing them to
MPT-dependent illness after exposure to salicylate, valproic acid and
other Reye-related toxicants.
4. Calcium and oxidative stress-induced injury
The short-chain hydroperoxide, tert-butylhydroperoxide (TBH), is
an analog of the lipid hydroperoxides that form during oxidative
stress and ischemia–reperfusion. TBH is detoxiﬁed to t-butanol with
oxidation of glutathione, NADPH, and NADH by the concerted action
glutathione peroxidase, glutathione reductase, and the mitochondrial
NADP/NAD transhydrogenase [4,46]. In isolated mitochondria, TBH is
a potent inducer of the MPT [16]. Similarly in cultured hepatocytes,
TBH induces MPT-dependent cell killing [22]. After TBH, confocal
microscopy reveals sequential mitochondrial NAD(P)H oxidation,
increased mitochondrial free Ca2+, intramitochondrial generation of
reactive oxygen species (ROS), mitochondrial depolarization and
inner membrane permeabilization, as monitored with autoﬂuores-Fig. 1. Changes leading to onset of the MPT after oxidative stress to hepatocytes. After expos
(autoﬂuorescence), increased mitochondrial free Ca2+ (Rhod2), increased mitochond
permeabilization (calcein) and mitochondrial depolarization (TMRM), and cell death. The M
(BHB), mitochondrial Ca2+ chelation with BAPTA, antioxidants (diphenylphenylene diamine
from [6,37,38].cence, Rhod-2, dichloroﬂuorescein, TMRM and calcein, respectively
(Fig. 1) [6,37,38]. These events culminate in ATP depletion and cell
death. Chelation of intramitochondrial Ca2+ with BAPTA-AM pre-
vents the increase of mitochondrial free Ca2+ and also blocks
increased mitochondrial ROS formation but not early oxidation of
mitochondrial NAD(P)H. By contrast, inhibition of ROS generation
with desferal or diphenylphenylene diamine delays, but does not
block, increased mitochondrial Ca2+ after TBH. Thus, NAD(P)H
oxidation leads to mitochondrial Ca2+ loading, which in turn
promotes ROS formation and the MPT. Indeed, Ca2+ loading of
isolated mitochondria promotes ROS formation, although the
mechanism for this remains obscure [7]. In this way, increased
mitochondrial Ca2+ and ROS generation act synergistically to induce
the MPT in this model of oxidative stress.
5. Calcium, oxidative stress and MPT-dependent
ischemia–reperfusion injury in cardiac myocytes
In cardiac myocytes, both cytosolic and mitochondrial free Ca2+
increase transiently during the contractile cycle as part of excitation–
contraction coupling and possibly to stimulate mitochondrial ATP
production on a beat to beat basis [8,48]. Since MPT-dependent
ischemia–reperfusion injury is associated with Ca2+ overload and
hypercontracture, a reasonable expectation is that Ca2+ dysregulation
promotes MPT onset and ensuing cell death. After about 20 to 40 min
of reperfusion of ischemic cardiac myocytes, the MPT occurs as shown
bymitochondrial depolarization andmovement of calcein through the
mitochondrial inner membrane (Fig. 2) [26]. MPT onset afterure of hepatocytes to TBH, a sequence of events occurs: oxidation of GSH and NAD(P)H
rial ROS formation (dichloroﬂuorescein [DCF]), the MPT with inner membrane
PT is prevented or delayed by increased reduction of NAD(P)H with β-hydroxybutyrate
[DPPD] and desferal) and blockers of the MPT (triﬂuoperazine [TFZ] and CsA). Adapted
Fig. 2. The MPT and cell death after ischemia–reperfusion to adult rat cardiac myocytes. Mitochondria of myocytes were loaded with calcein by a cold-loading/warm incubation
procedure, and the cells were subjected to 3 h of anoxia at pH 6.2 (ischemia) followed by reoxygenation at pH 7.4 (reperfusion) in the absence (A) and presence (B) of 1 μM CsA.
Nuclear staining by red-ﬂuorescing propidium iodide (PI) detected loss of cell viability. Note that green mitochondrial calcein ﬂuorescence was retained at the end of ischemia,
indicating that PT pores were closed. After reperfusion in the absence of CsA (A), mitochondria released calcein into the cytosol beginning after as early as 10 min. After 60 min, all
cellular calceinwas lost, and PI nuclear staining signiﬁed loss of cell viability. In the presence of CsA added at reperfusion (B), mitochondrial release of calceinwas greatly diminished
and viability was maintained for more than an hour. Adapted from [26].
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quickly by hypercontracture and cell death (Fig. 3). Antioxidants and
MPT blockers like CsA and its non-immunosuppressive analog, N-
methyl-4-isoleucine cyclosporin (NIM811), prevent the MPT, depolar-
ization, hypercontraction, and cell killing (Fig. 2). Antioxidants but not
MPT blockers inhibit ROS formation after reperfusion, signifying that
ROS generation is upstream of MPT induction (Fig. 3).
Although both cytosolic and mitochondrial free Ca2+ increase
markedly during ischemia, both Ca2+ pools recover to near normal in
the ﬁrst few minutes after reperfusion (Fig. 4). Late after reperfusion,
mitochondrial and cytosolic Ca2+ overloading again occurs, but CsA
and NIM811 block this late Ca2+ overloading (Fig. 4). Moreover,
intramitochondrial Ca2+ chelation by cold-loading/warm incubation
of BAPTA did not decrease cell death after reperfusion. These data
indicate that mitochondrial ROS generation after reperfusion pro-
motes MPT onset and subsequent myocyte death. Unexpectedly, late
Ca2+ overloading is not a factor inducing the MPT after reperfusion.
Rather, Ca2+ overloading is a consequence of bioenergetic failure
following MPT onset. Since mitochondrial BAPTA loading fails to
suppress cell death after reperfusion, mitochondrial Ca2+ appears not
to have even a permissive role for onset of theMPTafter reperfusion of
cardiac myocytes [26].
6. Role of the mitochondrial permeability transition in
storage-reperfusion injury to transplanted liver grafts
Because cardiac myocytes experience constant ﬂuctuations of free
Ca2+, their mitochondria may adapt to become resistant to Ca2+
induction of the MPT. Such an adaptation may not occur in non-
excitable tissues, such as liver, which are also vulnerable to MPT-
dependent ischemia-reperfusion injury [27,43]. A clinically important
form of ischemia-reperfusion injury to liver is that associated with
cold ischemic storage of livers for transplantation surgery and which
can lead to liver graft dysfunction and failure. When rat livers are
stored 18 h in University of Wisconsin cold storage solution and
transplanted, intravital (in vivo) confocal/multiphoton microscopy
reveals mitochondrial depolarization and loss of cell viability of
hepatocytes at 4 h after implantation in association with transami-
nase release and subsequent development of histological necrosis
[47]. Within individual hepatocytes, mitochondria depolarization isan all or nothing phenomena. Graft and recipient treatment with the
non-immunosuppressive MPT blocker, NIM811, prevents mitochon-
drial depolarization, decreases cell killing and transaminase release
and improves graft survival. NIM811 also decreases apoptosis after
transplantation as assessed by deoxynucleotidyl transferase-
mediated nick-end labeling (TUNEL) and caspase 3 measurements.
Thus, the MPT plays an important role in storage-reperfusion injury
to liver grafts.
Minocycline is a semisynthetic tetracycline antibiotic shown to be
protective in neurodegenerative disease, trauma, and hypoxia–
ischemia [9,14,15,24,52–55]. Cytoprotective mechanisms proposed
for minocycline include inhibition of apoptotic pathways, decreased
mitochondrial release of pro-apoptotic factors such as cytochrome c
[55], up-regulation of antiapoptotic proteins [52], inhibition of
caspase-1 and caspase-3 activation and suppression of cytochrome c
release [52,55]. After cold storage, reperfusion and transplantation of
rat livers, minocycline but not tetracycline decreases graft injury,
improves graft survival, minimizes mitochondrial depolarization and
decreases cell death as effectively as NIM811. In isolated rat liver
mitochondria, minocycline and NIM811 but not tetracycline block the
MPT. By contrast to NIM811 which does not block mitochondrial Ca2+
uptake, minocycline blocks onset of the MPT by inhibiting mitochon-
drial Ca2+ uptake (Fig. 5). Thus, minocycline represents a new
inhibitor class for the mitochondrial electrogenic Ca2+ uniporter. An
implication of minocycline protection against the MPT after storage-
reperfusion graft injury is that Ca2+ plays a role in MPT induction in
this model. So far, it has not been possible to visualize cytosolic and
mitochondrial free Ca2+ in this in vivo model, but previous work in
cultured hepatocytes indicates that cytosolic free Ca2+ does not
increase during hypoxia [32]. Thus, Ca2+ may be permissive in MPT
onset after storage-reperfusion with other factors such as ROS
formation decreasing the threshold for a Ca2+-induced MPT.
7. Conclusion
While a role for the MPT in the pathobiology of cell death is
strongly supported by experimental data for a number of models of
cell injury, the importance of Ca2+ in MPT induction seems to vary
with the particular set of circumstances. Certainly, Ca2+ overload
when it occurs can be sufﬁcient to induce the MPT, as occurs with
Fig. 3. Cyclosporin A-insensitive formation of mitochondrial ROS after reperfusion. Myocytes were co-loaded with TMRM and chloromethyldihydrodichloroﬂuorescein (cmDCF) to
monitor mitochondrial membrane potential and ROS formation, respectively, and subjected to ischemia–reperfusion as described in Fig. 2. Note loss of red TMRM ﬂuorescence after
3 h of ischemia, signifying depolarization. After reperfusion, mitochondria accumulated TMRM, indicating repolarization, and green cmDCF ﬂuorescence increased progressively inside
mitochondria. In the absence of CsA (A), the myocyte hypercontracted and depolarized after 40 min, and lost viability after 120 min, as shown by nuclear PI labeling. When myocytes
were reperfused in the presence of CsA (B), mitochondria repolarization was sustained, and cell death did not occur, but mitochondrial cmDCF still increased. Adapted from [26].
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reperfusion of ischemic cardiac myocytes, Ca2+ overload is the
consequence of bioenergetic failure after MPT onset rather than its
cause. Even intracellular Ca2+ chelation does not suppress MPT onset
and subsequent cell death after reperfusion of cardiac myocytes. In
other models, such as cytotoxicity from Reye-related agents and
storage-reperfusion injury to liver grafts, Ca2+ appears to beFig. 4. Change of cytosolic and mitochondrial free Ca2+ changes during ischemia–reperfu
monitored with Rhod-2 and Fluo-4, respectively, during ischemia–reperfusion to cardiac mpermissive to MPT onset. Reye-related toxicants lower the threshold
for Ca2+ induction of the MPT, and modulation of cellular Ca2+ up or
down has a corresponding effect on Reye toxicant-induced cell death.
In liver grafts, minocycline protects against MPT onset and graft
failure apparently by inhibiting mitochondrial Ca2+ uptake. The
implication is that Ca2+ is at minimum permissive for MPT onset in
the liver grafts. Lastly in a model of oxidative stress with TBH,sion to cardiac myocytes. Relative changes of mitochondrial and cytosolic Ca2+ were
yocytes. Adapted from [26].
Fig. 5. Minocycline inhibits calcium uptake and onset of the MPT in isolated rat liver
mitochondria. In the top panel, onset of the MPT was monitored by mitochondrial
swelling as determined from decreased absorbance. CaCl2 (250 μM) was added as
indicated in mitochondria pretreated with minocycline (Mino), tetracycline (Tetra),
1 μM CsA or no addition. In the middle and lower panels, extramitochondrial free Ca2+
was measured by Fluo-5N ﬂuorescence. As indicated, mitochondria were pre-incubated
with vehicle, 5 μM NIM811, 1 μM CsA, 18 μM minocycline or 18 μM tetracycline. CaCl2
was then added in 50 μM increments. Note that minocycline inhibits mitochondrial
swelling (the MPT) in a dose-dependent fashion. Minocycline also inhibits mitochon-
drial accumulation after each Ca2+ pulse. In the absence of minocycline, mitochondria
rapidly accumulate each pulse of Ca2+ until onset of the MPT when all accumulated
Ca2+ is abruptly released. Adapted from [47].
1400 J.J. Lemasters et al. / Biochimica et Biophysica Acta 1787 (2009) 1395–1401increased mitochondrial Ca2+ and ROS generation act synergistically
to produce the MPT and cell death. Thus, Ca2+ can be involved in
MPT onset in a number of ways, but the exact role of Ca2+ depends
on the particular biologic setting.
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